The Long-Term Condition (ALD) scheme reduces out-of-pocket expenses for patients with serious illnesses. In 2025, 15 million people will benefit from this scheme, representing 22% of insured individuals. Diabetes and cancer are the most common conditions. The total cost of the ALD scheme will reach €19.7 billion, steadily increasing due to the aging population and the rise in treatments.